Patient-Derived Organoids for In Vivo Validation of In Vitro Data-Reference-Cited by-同舟云学术

Patient-Derived Organoids for In Vivo Validation of In Vitro Data

Published:2022-10-19 Issue: Volume: Page:111-126
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Kdimati Said,Bürtin Florian,Linnebacher Michael,Mullins Christina Susanne

Publisher

Springer US

Link

https://link.springer.com/content/pdf/10.1007/978-1-0716-2788-4_8

Reference57 articles.

1. International Agency for Research on Cancer Cancer Today. https://gco.iarc.fr/today/home

2. Ewing I, Hurley JJ, Josephides E et al (2014) The molecular genetics of colorectal cancer. Frontline Gastroenterol 5:26–30. https://doi.org/10.1136/flgastro-2013100329

3. Sideris M, Papagrigoriadis S (2014) Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer. Anticancer Res 34:2061–2068

4. Kekelidze M, D’Errico L, Pansini M et al (2013) Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation. World J Gastroenterol 19:8502–8514. https://doi.org/10.3748/wjg.v19.i46.8502

5. Colussi D, Brandi G, Bazzoli F et al (2013) Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 14:16365–16385. https://doi.org/10.3390/ijms140816365

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease;JCI Insight;2023-09-22

2. Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease;2023-03-07